Literature DB >> 10718376

Role of hyperbaric oxygen exposure in reduction of lipid peroxidation and in multiple organ failure induced by zymosan administration in the rat.

S Cuzzocrea1, F Imperatore, G Costantino, C Luongo, E Mazzon, M A Scafuro, G Mangoni, A P Caputi, F Rossi, A Filippelli.   

Abstract

The aim of the present study was to evaluate the effects of hyperbaric oxygen (HBO) therapy on multiple organ failure induced by zymosan. Administration of zymosan (500 mg/kg) in the rat induced neutrophil infiltration in the lung, liver, and intestine as evaluated by increase in myeloperoxidase (MPO) activity. Therefore, lipid peroxidation was significantly increased in zymosan-treated rats. This inflammatory process coincided with the damage of lung, liver, and small intestine. Immunohistochemical examination demonstrated a marked increase in the immunoreactivity to nitrotyrosine in the lung, liver, and small intestine of zymosan-shocked rats. HBO (2 absolute Atmosphere) exposure attenuates the increase in the tissue levels of MPO and malondialdehyde (MDA) caused by zymosan in the lung, liver, and intestine. In addition, HBO (2 absolute Atmosphere) was effective in preventing the development of lung, liver, and intestine injury. Taken together, the present results demonstrate that HBO may also be an efficacious treatment in multiple organ failure induced by zymosan.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10718376     DOI: 10.1097/00024382-200003000-00005

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  11 in total

1.  Hyperbaric oxygen in systemic inflammatory response.

Authors:  Haim Bitterman; Claus-Martin Muth
Journal:  Intensive Care Med       Date:  2004-03-18       Impact factor: 17.440

2.  Hyperbaric oxygen and sepsis: time to recognize.

Authors:  Claus-Martin Muth; Peter Radermacher; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2005-07-21       Impact factor: 17.440

3.  Can (hyperbaric) oxygen turn off the motor of multiorgan dysfunction?

Authors:  Sükrü Oter; Peter Radermacher; Martin Matejovic
Journal:  Intensive Care Med       Date:  2006-09-30       Impact factor: 17.440

Review 4.  Hyperbaric Oxygen Therapy-A Novel Treatment Modality in Oral Submucous Fibrosis: A Review.

Authors:  M Ashwini Kumar; Besta Radhika; Nishanth Gollamudi; Satya Prakash Reddy; Uday Shankar Yaga
Journal:  J Clin Diagn Res       Date:  2015-05-01

5.  Hyperbaric oxygen therapy reduces the toll-like receptor signaling pathway in multiple organ failures.

Authors:  Barbara Rinaldi; Salvatore Cuzzocrea; Maria Donniacuo; Annalisa Capuano; Donatella Di Palma; Francesco Imperatore; Emanuela Mazzon; Rosanna Di Paola; Loredana Sodano; Francesco Rossi
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

6.  The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage.

Authors:  Mustafa Edremitlioğlu; Dilek Kiliç; Sükrü Oter; Uçler Kisa; Ahmet Korkmaz; Omer Coşkun; Orhan Bedir
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

7.  Hyperbaric oxygen therapy prevents vascular derangement during zymosan-induced multiple-organ-failure syndrome.

Authors:  Francesco Imperatore; Salvatore Cuzzocrea; Carlo Luongo; Giovanni Liguori; Antonella Scafuro; Antonella De Angelis; Francesco Rossi; Achille P Caputi; Amelia Filippelli
Journal:  Intensive Care Med       Date:  2004-02-12       Impact factor: 17.440

8.  Hyperbaric oxygen treatment and nephrotoxicity induced by gentamicin in rats.

Authors:  Matitiahu Berkovitch; Yossi Shain; Eran Kozer; Michael Goldman; Ibrahim Abu-Kishk
Journal:  BMC Nephrol       Date:  2017-12-02       Impact factor: 2.388

9.  How biomarkers reflect the prognosis and treatment of necrotising soft tissue infections and the effects of hyperbaric oxygen therapy: the protocol of the prospective cohort PROTREAT study conducted at a tertiary hospital in Copenhagen, Denmark.

Authors:  Peter Polzik; Pär I Johansson; Ole Hyldegaard
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

Review 10.  Hyperbaric Oxygen Therapy in Liver Diseases.

Authors:  Yun Sun; Yankai Wen; Chanjuan Shen; Yuanrun Zhu; Wendong You; Yuanyuan Meng; Lijuan Chen; Yiping Feng; Xiaofeng Yang; Zuo-Bing Chen
Journal:  Int J Med Sci       Date:  2018-05-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.